ID   NANP_HUMAN              Reviewed;         248 AA.
AC   Q8TBE9; B3KP12; Q5JYN8; Q8TE97; Q9Y3N0;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   15-MAR-2017, entry version 130.
DE   RecName: Full=N-acylneuraminate-9-phosphatase;
DE            EC=3.1.3.29;
DE   AltName: Full=Haloacid dehalogenase-like hydrolase domain-containing protein 4;
DE   AltName: Full=Neu5Ac-9-Pase;
GN   Name=NANP; Synonyms=C20orf147, HDHD4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CATALYTIC ACTIVITY, COFACTOR, ENZYME REGULATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16237198; DOI=10.1093/glycob/cwj050;
RA   Maliekal P., Vertommen D., Delpierre G., Van Schaftingen E.;
RT   "Identification of the sequence encoding N-acetylneuraminate-9-
RT   phosphate phosphatase.";
RL   Glycobiology 16:165-172(2006).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH PHOSPHATE IONS.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of human N-acetylneuraminic acid phosphatase,
RT   NANP.";
RL   Submitted (DEC-2008) to the PDB data bank.
CC   -!- CATALYTIC ACTIVITY: N-acylneuraminate 9-phosphate + H(2)O = N-
CC       acylneuraminate + phosphate. {ECO:0000269|PubMed:16237198}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:16237198};
CC   -!- ENZYME REGULATION: Inhibited by vanadate and calcium.
CC       {ECO:0000269|PubMed:16237198}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.09 mM for N-acetylneuraminate 9-P
CC         {ECO:0000269|PubMed:16237198};
CC         KM=19.2 mM for fructose 1,6-P2 {ECO:0000269|PubMed:16237198};
CC         KM=2.7 mM for 6-P-gluconate {ECO:0000269|PubMed:16237198};
CC         KM=5.9 mM for N-acetylglucosamine 6-P
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=112 umol/min/mg enzyme with N-acetylneuraminate 9-P as
CC         substrate {ECO:0000269|PubMed:16237198};
CC         Vmax=6.10 umol/min/mg enzyme with fructose 1,6-P2 as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=2.79 umol/min/mg enzyme with 6-P-gluconate as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=2.46 umol/min/mg enzyme with N-acetylglucosamine 6-P as
CC         substrate {ECO:0000269|PubMed:16237198};
CC         Vmax=0.149 umol/min/mg enzyme with sorbitol 6-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.140 umol/min/mg enzyme with 3-P glycerate as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.095 umol/min/mg enzyme with P-serine as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.094 umol/min/mg enzyme with glycerol 3-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.090 umol/min/mg enzyme with ribulose 5-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.072 umol/min/mg enzyme with N-acetylmannosamine 6-P as
CC         substrate {ECO:0000269|PubMed:16237198};
CC         Vmax=0.063 umol/min/mg enzyme with arabinose 6-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.042 umol/min/mg enzyme with ribose 6-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.023 umol/min/mg enzyme with glucosamine 6-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.019 umol/min/mg enzyme with phosphoglycolate as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.019 umol/min/mg enzyme with fructose 6-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.017 umol/min/mg enzyme with glycerol 2-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.016 umol/min/mg enzyme with glucose 6-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.015 umol/min/mg enzyme with mannose 6-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.004 umol/min/mg enzyme with glucose 1-P as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.002 umol/min/mg enzyme with P-enolpyruvate as substrate
CC         {ECO:0000269|PubMed:16237198};
CC         Vmax=0.001 umol/min/mg enzyme with ATP as substrate
CC         {ECO:0000269|PubMed:16237198};
CC   -!- PATHWAY: Amino-sugar metabolism; N-acetylneuraminate biosynthesis.
CC   -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily. NANP
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB85055.1; Type=Miscellaneous discrepancy; Note=It seems to be derived from genomic DNA and not from cDNA.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK055472; BAG51524.1; -; mRNA.
DR   EMBL; AK074335; BAB85055.1; ALT_SEQ; mRNA.
DR   EMBL; AL031673; CAI22444.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10081.1; -; Genomic_DNA.
DR   EMBL; BC022552; AAH22552.1; -; mRNA.
DR   CCDS; CCDS13173.1; -.
DR   RefSeq; NP_689880.1; NM_152667.2.
DR   UniGene; Hs.143137; -.
DR   UniGene; Hs.606268; -.
DR   PDB; 2W4M; X-ray; 2.60 A; A=1-248.
DR   PDB; 4KNV; X-ray; 1.99 A; A/B=7-242.
DR   PDB; 4KNW; X-ray; 2.70 A; A/B/C=2-248.
DR   PDBsum; 2W4M; -.
DR   PDBsum; 4KNV; -.
DR   PDBsum; 4KNW; -.
DR   ProteinModelPortal; Q8TBE9; -.
DR   SMR; Q8TBE9; -.
DR   BioGrid; 126729; 10.
DR   IntAct; Q8TBE9; 6.
DR   STRING; 9606.ENSP00000302441; -.
DR   BindingDB; Q8TBE9; -.
DR   ChEMBL; CHEMBL2401602; -.
DR   DEPOD; Q8TBE9; -.
DR   iPTMnet; Q8TBE9; -.
DR   PhosphoSitePlus; Q8TBE9; -.
DR   BioMuta; NANP; -.
DR   DMDM; 30315932; -.
DR   EPD; Q8TBE9; -.
DR   MaxQB; Q8TBE9; -.
DR   PaxDb; Q8TBE9; -.
DR   PeptideAtlas; Q8TBE9; -.
DR   PRIDE; Q8TBE9; -.
DR   DNASU; 140838; -.
DR   Ensembl; ENST00000304788; ENSP00000302441; ENSG00000170191.
DR   GeneID; 140838; -.
DR   KEGG; hsa:140838; -.
DR   UCSC; uc002wuy.5; human.
DR   CTD; 140838; -.
DR   DisGeNET; 140838; -.
DR   GeneCards; NANP; -.
DR   HGNC; HGNC:16140; NANP.
DR   HPA; HPA050342; -.
DR   MIM; 610763; gene.
DR   neXtProt; NX_Q8TBE9; -.
DR   OpenTargets; ENSG00000170191; -.
DR   PharmGKB; PA25689; -.
DR   eggNOG; KOG3085; Eukaryota.
DR   eggNOG; COG1011; LUCA.
DR   GeneTree; ENSGT00390000003094; -.
DR   HOGENOM; HOG000248345; -.
DR   HOVERGEN; HBG051895; -.
DR   InParanoid; Q8TBE9; -.
DR   KO; K01097; -.
DR   OMA; YHPALRD; -.
DR   OrthoDB; EOG091G0G6E; -.
DR   PhylomeDB; Q8TBE9; -.
DR   TreeFam; TF324589; -.
DR   BioCyc; MetaCyc:HS10082-MONOMER; -.
DR   Reactome; R-HSA-4085001; Sialic acid metabolism.
DR   SABIO-RK; Q8TBE9; -.
DR   UniPathway; UPA00630; -.
DR   EvolutionaryTrace; Q8TBE9; -.
DR   GenomeRNAi; 140838; -.
DR   PRO; PR:Q8TBE9; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000170191; -.
DR   CleanEx; HS_NANP; -.
DR   Genevisible; Q8TBE9; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0050124; F:N-acylneuraminate-9-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006045; P:N-acetylglucosamine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046380; P:N-acetylneuraminate biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.40.50.1000; -; 2.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006439; HAD-SF_hydro_IA.
DR   InterPro; IPR011950; HAD-SF_hydro_IA_CTE7.
DR   Pfam; PF13419; HAD_2; 1.
DR   PRINTS; PR00413; HADHALOGNASE.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR02253; CTE7; 1.
DR   TIGRFAMs; TIGR01549; HAD-SF-IA-v1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carbohydrate metabolism; Complete proteome; Hydrolase;
KW   Magnesium; Reference proteome.
FT   CHAIN         1    248       N-acylneuraminate-9-phosphatase.
FT                                /FTId=PRO_0000083938.
FT   REGION       12     14       Substrate binding.
FT   REGION      131    132       Substrate binding.
FT   BINDING     164    164       Substrate.
FT   CONFLICT     32     55       IKLLQSKYHYKEEAEIICDKVQVK -> TSPPMALLWAGSV
FT                                RPAPSCTLTSP (in Ref. 1; BAB85055).
FT                                {ECO:0000305}.
FT   STRAND        8     11       {ECO:0000244|PDB:4KNV}.
FT   TURN         15     17       {ECO:0000244|PDB:4KNV}.
FT   HELIX        20     38       {ECO:0000244|PDB:4KNV}.
FT   HELIX        44     58       {ECO:0000244|PDB:4KNV}.
FT   TURN         63     65       {ECO:0000244|PDB:2W4M}.
FT   HELIX        68     84       {ECO:0000244|PDB:4KNV}.
FT   HELIX        90    107       {ECO:0000244|PDB:4KNV}.
FT   HELIX       112    122       {ECO:0000244|PDB:4KNV}.
FT   STRAND      125    131       {ECO:0000244|PDB:4KNV}.
FT   HELIX       135    144       {ECO:0000244|PDB:4KNV}.
FT   HELIX       148    150       {ECO:0000244|PDB:4KNV}.
FT   STRAND      152    156       {ECO:0000244|PDB:4KNV}.
FT   HELIX       157    159       {ECO:0000244|PDB:4KNV}.
FT   STRAND      160    162       {ECO:0000244|PDB:4KNV}.
FT   HELIX       167    176       {ECO:0000244|PDB:4KNV}.
FT   HELIX       181    183       {ECO:0000244|PDB:4KNV}.
FT   STRAND      184    189       {ECO:0000244|PDB:4KNV}.
FT   TURN        191    193       {ECO:0000244|PDB:4KNV}.
FT   HELIX       194    200       {ECO:0000244|PDB:4KNV}.
FT   STRAND      204    209       {ECO:0000244|PDB:4KNV}.
FT   STRAND      224    228       {ECO:0000244|PDB:4KNV}.
FT   HELIX       230    232       {ECO:0000244|PDB:4KNV}.
FT   HELIX       233    237       {ECO:0000244|PDB:4KNV}.
FT   TURN        238    241       {ECO:0000244|PDB:4KNV}.
SQ   SEQUENCE   248 AA;  27813 MW;  360E6D7AB965294B CRC64;
     MGLSRVRAVF FDLDNTLIDT AGASRRGMLE VIKLLQSKYH YKEEAEIICD KVQVKLSKEC
     FHPYNTCITD LRTSHWEEAI QETKGGAANR KLAEECYFLW KSTRLQHMTL AEDVKAMLTE
     LRKEVRLLLL TNGDRQTQRE KIEACACQSY FDAVVVGGEQ REEKPAPSIF YYCCNLLGVQ
     PGDCVMVGDT LETDIQGGLN AGLKATVWIN KNGIVPLKSS PVPHYMVSSV LELPALLQSI
     DCKVSMST
//
